| Trial ID: | L2382 |
| Source ID: | NCT00549874
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Rosiglitazone|DRUG: Glyburide
|
| Outcome Measures: |
Primary: Myocardial blood flow regulation, 6 months intervention | Secondary: biomarkers of oxidative/nitrosative stress, 6 month intervention
|
| Sponsor/Collaborators: |
Sponsor: University of Michigan | Collaborators: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
27
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2002-02
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2007-11-09
|
| Locations: |
University of Michigan, Ann Arbor, Michigan, 48109, United States|University of Toledo - Health Campus, Toledo, Ohio, 43606, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00549874
|
